1. Introduction {#s0005}
===============

Diabetes mellitus is a group of metabolic disorders of glucose characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both ([@b0115]). Insulin is normally produced in highly specialized cells of the endocrine pancreas. The tissue-specific expression of insulin is tightly regulated at the transcriptional level, and the major regulatory elements are located in the 5′ flanking region of the insulin gene ([@b0125]). Insulin expression is specific to β cells in the pancreatic islets, although proinsulin has also been detected in the fetal and postnatal thymus and spleen--lymphoid tissues ([@b0165]) In spite of the introduction of hypoglycemic drugs, diabetes and related complications continue to be a major medical problem ([@b0120]). In addition, hyper glycemia in diabetic patients is associated with alteration in glucose and lipid metabolism and modification in liver enzyme levels ([@b0075]).

Hyperglycemia generates reactive oxygen species (ROS), which in turn cause damage to the cells in many ways. Damage to the cells ultimately results in secondary complications in diabetes mellitus. So, oxidative stress is thought to be a major contributor to cardiovascular disease in diabetes mellitus. In fact, it is well documented that diabetes is associated with increased oxidative stress, as evidenced by the increased accumulation of lipid peroxidase in the plasma of diabetes mellitus ([@b0060], [@b0080], [@b0130], [@b0065], [@b0070], [@b0150]).

Biotin is a hydrosoluble vitamin that acts as a prosthetic group of carboxylases. Unrelated to its role as carboxylase prosthetic group, biotin regulates gene expression ([@b0140], [@b0045]) and has a wide repertoire of effects on systemic processes such as development ([@b0160]) and immunity ([@b0020]). The first evidence that biotin affects glucose metabolism was reported by [@b0040] in biotin-deficient rats. They observed that glucose tolerance test curves in biotin-deficient rats were significantly higher than those in nondeficient rats, as well as glucose phosphorylation and incorporation into glycogen in the liver. [@b0145] demonstrated that insulin expression and secretion were increased in response to biotin. On the other hand, biotin deficiency decreased pancreatic glucokinase activity and decreased insulin secretion from pancreas.

2. Material and methods {#s0010}
=======================

2.1. Animals {#s0015}
------------

Male mice of the Swiss albino strain weighing 25 ± g were used for the experiment, aged 12 weeks. The animals were acclimated to 22 ± 1 °C and maintained under conditions of 12-h periods of light and dark, with free access to clean water and commercial mice food. The animals were housed in polypropylene cages inside a well-ventilated room. The experiments were approved by the state authorities and followed Saudi Arabian rules of animal protection.

2.2. Induction of diabetes mellitus {#s0020}
-----------------------------------

All mice were fasted for 20 h before diabetes was induced by Streptozotocin (STZ) injection which was obtained from Sigma Chemicals Co., St. Louis, MO, USA. STZ dissolved in cold 0.01 M citrate buffer, pH 4.5 (always prepared fresh for immediate use within 5 min). STZ single dose injection (150 mg/kg) was given intraperitoneally. The blood glucose concentration was measured after 3 days of STZ injection for diabetes induction confirmation. The blood samples were collected from the tail and deproteinized. The obtained supernatant was immediately used for the determination of blood glucose by glucose oxidase/peroxidase spectrophotometry method (Braham and Tinder, 1972).

2.3. Experimental groups and protocol {#s0025}
-------------------------------------

The animals were distributed into three experimental groups. Each group consists of 10 mice in the beginning of the study. Animals in group I that served as the control group were injected with equivalent amount of cold citrate buffer (pH 4.5). Animals in group II were intraperitoneally administered single injection of 150 mg/kg of STZ. Animals in group III were intraperitoneally administered single injection of 150 mg/kg of STZ and received 15 mg/kg of biotin orally by stomach gavage daily for 12 days (biotin treatment was carried out after 3 days of STZ injection and glucose test was performed) ([@b0135], [@b0010]). All animals were killed by ether at the end of experiment, blood samples and liver samples were collected.

2.4. Liver index {#s0030}
----------------

At the end of the experimental period, each mouse was weighed; livers were removed and weighed. Finally, the liver index was calculated by dividing the liver weight by the body weight and then multiplying by 100 and the results were statistically analyzed by SPSS (16.0).

2.5. Biochemical analysis {#s0035}
-------------------------

Blood samples for the measurement of blood chemistry were drawn into prechilled EDTA-containing tubes and immediately placed on ice. Blood samples were centrifuged at 3000 r/m for separation of serums and stored at −8 °C until assay. Serums were used for the estimation of glucose, ALT and AST.

2.6. Histological examination and histopathological score system {#s0040}
----------------------------------------------------------------

Livers were collected and cut into small pieces, fixed in 10% neutral buffered formalin. Following fixation, specimens were dehydrated, embedded in wax, and then sectioned to 5 μm thicknesses. Sections were stained with hematoxylin and eosin.

2.7. Histopathological score system {#s0045}
-----------------------------------

For the microscopic analysis, the liver fragment slides were stained with hematoxylin and eosin (HE). The scoring system was recommended by the Pathology Committee of NASH Clinical Research Network ([@b0090]). Steatosis, normal (\<5%) = 0, 5--33% = 1, 33--66% = 2 and \>66% = 3, Microvesicular steatosis, none = 0 and present = 1, Inflammation, none = 0, \<2 foci per 200× field = 1, 2--4 foci per 200× field = 2, \>4 foci per 200× field = 3, Ballooning, none = 0, few balloon cells = 1, many cells = 2, prominent balloon cells = 3, the overall results represented as follows 0 = normal, 1 = mild, 2 = moderate and 3 = severe.

2.8. Immunohistochemical localization of acrolein (ABC method) {#s0050}
--------------------------------------------------------------

Paraffin embedded kidney sections were deparaffinized in xylene and rehydrated in descending grades of alcohol and finally distilled water. Sections then were heated in citrate buffer (pH 6) within microwave for 5 min. After that sections were washed with PBS buffer for 5 min and incubated in peroxidase blocking solution for 10 min. Sections were incubated overnight at 4 °C in diluted primary antibody (anti-acrolein) (mouse monoclonal antibody ab48501) then incubated in biotinylated goat anti-mouse (ab128976) as secondary antibody for 30 min, followed by incubation in avidin--biotin complex for 30 min, then incubated in DAB (ab64238) as chromogenic substrate for ten minutes, The stained sections were counter stained with Mayer's hematoxylin, and dehydrated within ascending grades of alcohol and cleared with two changes of xylene, mounted with cover slip based on DPX mountant (all reagents from Abcam company). Liver sections were examined under microscope for brown immunoreactivity color and photos at magnification 200×.

2.9. Statistical analysis {#s0055}
-------------------------

Statistical significance of the control and diabetic mice groups was evaluated by SPSS16.0 (One-way *T* test). Comparison was made between control and diabetic groups in mice weight, liver weight, liver index, glucose levels, ALT and AST, *p* \< 0.05 was considered to be significant.

3. Results {#s0060}
==========

3.1. Weight and liver index {#s0065}
---------------------------

Weight of mice showed no change in the untreated diabetic group compared with the control group, whereas treated diabetic group with biotin showed an insignificant increase in mice weights compared with the control group ([Table 1](#t0005){ref-type="table"}). Weights of livers of untreated and treated diabetic groups showed no change compared with the control group. Liver index showed no change in the untreated diabetic group compared with the control group ([Table 1](#t0005){ref-type="table"}), moreover treated diabetic group with biotin showed an insignificant decrease compared with the control group.

3.2. Biochemical analysis {#s0070}
-------------------------

Glucose levels showed a significant increase in untreated and treated diabetic groups compared with the control group *p* \< 0.05 ([Table 2](#t0010){ref-type="table"}) whereas, glucose level showed a significant decrease *p* \< 0.05 in treated diabetic with biotin group versus untreated diabetic group. AST and ALT levels showed a significant decrease in untreated and treated groups versus control group *p* \< 0.05 ([Table 2](#t0010){ref-type="table"}). Moreover, treated diabetic with biotin group showed a significant decrease versus untreated diabetic group *p* \< 0.05.

3.3. Histopathological and immunohistochemistry analysis {#s0075}
--------------------------------------------------------

Control mice liver section showed normal liver architecture consisting of central vein and anastomose network of healthy hepatocytes arranged in strands, some of them showed double nuclei as a result of regeneration, strands of hepatocytes separated from each other by blood sinusoids, Kupffer cells were abundant in the sinusoids ([Fig. 1](#f0005){ref-type="fig"}), all items of histopathological score showed 0 = normal ([Table 3](#t0015){ref-type="table"}).

Histopathological examination of diabetic mice liver shows severe pathological alterations manifested by dilated and congested portal vein with destructed wall surrounded by leukocytic infiltration. Hepatocytes suffered from severe cytoplasmic degeneration ([Fig. 2](#f0010){ref-type="fig"}), most of cells showed pyknotic nuclei and karyolysed nuclei. Neutrophilic and eosinophilic aggregation was abundant in the tissue besides necrotic areas ([Figure 3](#f0015){ref-type="fig"}, [Figure 4](#f0020){ref-type="fig"}), some cells showed microvesicular steatosis (fatty degeneration) ([Fig. 5](#f0025){ref-type="fig"}), histopathological scoring showed moderate steatosis score (2), positive for microvesicular steatosis, moderate inflammation score (2) and severe ballooning score (3) ([Table 3](#t0015){ref-type="table"}). Testing of diabetic liver section for anti-acrolein gene expression by the ABC method showed intense brownish immune precipitate in the tissue that referred to oxidative stress (acrolein is a main product of lipid peroxidation resulted from oxidative stress), immuoprecipitate accumulated in the cells and around central vein ([Fig. 6](#f0030){ref-type="fig"}).

Examination of diabetic mice liver treated with biotin showed to great extent improved sections represented by normal shape of central vein surrounded by a few scattered leukocytes and more healthy hepatocytes, binucleated cells were present as a result of regeneration ([Fig. 7](#f0035){ref-type="fig"}), some cells showed pyknotic nuclei ([Fig. 8](#f0040){ref-type="fig"}), histopathological scoring system showed mild steatosis score (1), negative to microvesicular steatosis, mild inflammation score (1) and normal score (0) for ballooning ([Table 3](#t0015){ref-type="table"}). Testing of diabetic liver sections treated with biotin to anti-acrolein gene expression showed faintly stained brownish immunoprecipitate compared with untreated diabetic liver section ([Fig. 9](#f0045){ref-type="fig"}), that referred to reduction in oxidative stress.

4. Discussion {#s0080}
=============

Diabetes is by far the most common of endocrine disorders and a major threat to health care worldwide. It is projected that by 2010, at least 239 million people will be affected by the disease ([@b0105]). Streptozotocin induced diabetes provides a relevant example of endogenous chronic oxidative stress due to the resulting hyperglycemia ([@b0100]). STZ is a pancreatic β cell toxin that induces rapid and irreversible necrosis of cells ([@b0015]) whereas a single diabetogenic dose of STZ (70--250 mg/kg, body weight) has been demonstrated to induce complete destruction of β cells in most species within 24 h, multiple sub-diabetogenic doses of STZ partially damage islets, thereby triggering an inflammatory process leading to macrophage and subsequent lymphocyte infiltration, which is followed by the onset of insulin deficiency ([@b0095]). The present results run in full agreement with the previous studies that single dose of 150 mg/kg of STZ induced damage for β cells in pancreas resulted in diabetes type 1 in mice after 3 days.

Diabetic albino rats STZ-induced registered significant decrease in weights and significant increase in liver weights at variable time intervals ([@b0170]). Moreover, the body weight of diabetic mice was significantly lowered than that of the nondiabetic group and relative weights of liver were significantly higher in diabetic mice compared to nondiabetic control mice ([@b0085]). In contrast to the previous studies, the present results showed no change in diabetic mice weight compared to control mice and insignificant increase in treated diabetic mice with biotin compared to control and diabetic mice whereas, liver weight registered no change among control and diabetic groups. Many studies revealed that mice that received single dose of STZ showed an increase in glucose, ALT and AST levels ([@b0175], [@b0170], [@b0005], [@b0085]). The present results agreed with the previous studies that single dose of STZ caused a significant increase in glucose level in diabetic mice compared to control mice, whereas, diabetic mice treated with biotin showed a significant decrease in glucose level compared to untreated diabetic mice that agreed with [@b0025], [@b0110] who showed that biotin lowered the fasting glucose of diabetes patients and increased lymphocyte activity that was explained by [@b0145] who proved that biotin stimulates hepatic and pancreatic glucokinase, an enzyme that plays an important role in glucose homeostasis regulating insulin secretion in response to changes in blood glucose concentration and hence insulin expression and secretion were increased in response to biotin. [@b0030] stated that biotin reduced hyperglycemia in human patients type 1 received 16 mg/day of biotin for 1 week. In contrast to [@b0050], [@b0175], [@b0005] results that diabetic mice STZ induced showed an increase in ALT and AST, the present study revealed a decrease in ALT and AST in diabetic mice compared to control mice, moreover treated diabetic mice with biotin showed a decrease in ALT and AST compared to untreated diabetic mice that agreed with [@b0035].

In the present study, administration of single dose of STZ caused severe histopathological changes represented by dilated and congested portal vein, leukocytic infiltration, cytoplasmic degeneration and fatty degeneration, moderate steatosis and inflammation, whereas severe ballooning cells were registered in histopathological scoring system, these findings are in agreement with [@b0175], [@b0050] who showed dilatation of veins, loss of usual arrangement of hepatocytes, lymphocytic infiltration and accumulation of lipid droplets in the cytoplasm of hepatocytes. In the present study administration of 15 mg/kg of biotin for 12 days revealed reduction of hepatotoxicity in diabetic mice STZ-induced manifested by healthy hepatocytes, binucleated cells as an evidence of regeneration and to some extent normal central vein, mild steatosis and inflammation whereas, no ballooning cells were registered in histopathological system score. There is increasing evidence that aldehydes generated endogenously during lipid peroxidation contribute to the pathophysiologic effects associated with oxidative stress in cells and tissues. A number of reactive lipid aldehydes, such as 4-hydroxy-2-alkenals and malondialdehyde, have been implicated as causative agents in cytotoxic processes initiated by the exposure of biologic systems to oxidizing agents. Recently, acrolein (CH~2~000000000000 000000000000 000000000000 111111111111 000000000000 111111111111 000000000000 000000000000 000000000000CH−CHO), a ubiquitous pollutant in the environment, was identified as a product of lipid peroxidation reactions. The identification of acrolein as an endogenous lipid-derived product suggests an examination of the possible role of this aldehyde as a mediator of oxidative damage in a variety of human diseases ([@b0155]). Lipid peroxidation is implicated in the pathogenesis of numerous diseases; including atherosclerosis, diabetes, cancer, and rheumatoid arthritis, as well as in drug-associated toxicity, post is chemic reoxygenation injury, and aging. Lipid peroxidation proceeds by a free-radical chain reaction mechanism and yields lipid hydroperoxides as major initial reaction products. Subsequently, decomposition of lipid hydroperoxides generates a number of degradation products that lead to a wide variety of damaging actions ([@b0055]). In the present study, untreated diabetic mice liver showed a positive intense immunoreaction for acrolein, whereas treated diabetic mice with biotin showed faintly immunoreactions or acrolein as evidence that biotin can reduce oxidative stress.

The present study aimed to investigate whether biotin, that is a kind of vitamin B could reduce hyperglycemia, hepatotoxicity and oxidative stress in the liver. The overall results showed that biotin could reduce glucose levels in diabetic mice STZ-induced, moreover, biotin could improve injured liver due to diabetes and reduce oxidative stress in liver.
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![Liver of control mice showed normal liver structure. (Hx &E- Mag×400).](gr1){#f0005}

![Liver section of diabetic mice STZ-induced showed dilated central vein (CV), cytoplasmic degeneration (black arrows), leukocytic infiltration (L) and pyknotic nuclei (green arrows). (Hx &E- Mag ×400).](gr2){#f0010}

![Liver section of diabetic mice STZ-induced showed aggregations of leukocytes (L) and degenerated cells (black arrows). (Hx &E- Mag ×400).](gr3){#f0015}

![Liver section of diabetic mice STZ-induced showed necrotic areas (N) and scattered inflammatory cells. (Hx &E- Mag ×400).](gr4){#f0020}

![Liver section of diabetic mice STZ-induced showed microvesicular fatty degeneration (arrow). (Hx &E- Mag ×400).](gr5){#f0025}

![Liver section of diabetic mice STZ-induced showed intense brown immunoprecipitate of antiacrolein in the cytoplasm of hepatocytes. (ABC method- Mag ×200).](gr6){#f0030}

![Liver section of diabetic mice STZ-induced and treated with biotin showed healthy hepatocytes and binucleated cells (arrows). (Hx &E- Mag ×400).](gr7){#f0035}

![Liver section of diabetic mice STZ-induced and treated with biotin showed normal central vein (CV) surrounded by a few number of inflammatory cells. (Hx &E- Mag ×400).](gr8){#f0040}

![Liver section of diabetic mice STZ-induced and treated with biotin showed faintly stained brown immunoprecipitate of anti acrolein (arrows) due to reduction of oxidative stress. (ABC method- Mag ×200).](gr9){#f0045}

###### 

Shows weights of mice, weights of livers and liver index in control, diabetes and diabetes treated with 15 mg/kg of biotin for 12 days after diabetes induction.

                    Control      Diabetes     Diabetes and biotin
  ----------------- ------------ ------------ ---------------------
  Weight of mice    25.7 ± 0.8   25.5 ± 4.3   31.5 ± 2.2
  Weight of liver   1.9 ± 0.3    1.9 ± 0.1    2 ± 0.3
  Liver index       7.6 ± 1.6    7.5 ± 0.7    6.4 ± 1.1

Data = Mean ± SEM (Standard Error of Means), *p* \< 0.05 considered significant difference when diabetic groups compared with control group.

###### 

Shows glucose, AST and ALT levels in control, untreated diabetes and diabetes treated with 15 mg/kg of biotin for 12 days after diabetes induction.

            Control     Diabetes                                    Diabetes and biotin
  --------- ----------- ------------------------------------------- -------------------------------------------
  Glucose   117 ± 0.8   333 ± 46                                    221 ± 82[⁎](#tblfn1){ref-type="table-fn"}
  AST       354 ± 2.3   250 ± 79[⁎](#tblfn1){ref-type="table-fn"}   167 ± 0
  ALT       223 ± 1.7   71 ± 27[⁎](#tblfn1){ref-type="table-fn"}    40 ± 10[⁎](#tblfn1){ref-type="table-fn"}

Data = Mean ± SEM (Standard Error of Means).

Significant difference in the group, *p* \< 0.05 considered significant difference when diabetic groups compared with control group.

###### 

Showed liver pathological score.

  Items                      Control   Diabetes                                      Diabetes and biotin
  -------------------------- --------- --------------------------------------------- ------------------------------------------
  Steatosis                  0         2.1 ± 0.08[⁎](#tblfn2){ref-type="table-fn"}   1 ± 0
  Microvesicular steatosis   0         1 ± 0.09[⁎](#tblfn2){ref-type="table-fn"}     0 ± 0.08
  Inflammation               0         2 ± 0.2[⁎](#tblfn2){ref-type="table-fn"}      1 ± 0.1[⁎](#tblfn2){ref-type="table-fn"}
  Ballooning                 0         3 ± 0.06[⁎](#tblfn2){ref-type="table-fn"}     0 ± 0.08

Data = Mean ± SEM (Standard Error of Means).

*p* \< 0.05 considered significant difference when diabetic groups compared with control group.
